Skip to content

MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid

Wendy M. Bosker, Kim P. C. Kuypers, Silke Conen, Gerold F. Kauert, Stefan W. Toennes, Gisela Skopp, Johannes G. Ramaekers

Psychopharmacology September 27, 2011 DOI: 10.1007/s00213-011-2497-8 via OpenAlex

Summary

AI-generated from the abstract

Taking MDMA (ecstasy) during the night does not improve driving performance the next morning after sleep loss, nor does it counteract the impairing effects of sleep deprivation. In a controlled driving test, weaving (measured as standard deviation of lateral position) was significantly increased during morning drives after a night without sleep, regardless of whether participants had taken 0, 25, 50, or 100 mg of MDMA the previous evening. The degree of impairment was clinically relevant and comparable to that seen with a blood alcohol concentration above 0.8 mg/mL. MDMA cannot compensate for sleep-loss-induced driving impairment, and sleep-deprived drivers who have taken MDMA are unfit to drive.

Study at a glance

Characteristics Randomized double-blind placebo-controlled four-way cross-over design Peer reviewed
Sample size 16
Population Recreational MDMA users
Intervention MDMA
Dose 0, 25, 50, and 100 mg
Duration Evening dosing, driving tests in the evening and the morning after a night of sleep loss
Topics MDMA
Keywords Evening Morning Sleep deprivation
Citations 32
Key finding MDMA did not affect driving performance nor change the impairing effects of sleep loss; sleep loss alone caused clinically relevant driving impairment.

Abstract

RATIONALE: Experimental research has shown that 3,4-methylenedioxymethamphetamine (MDMA) can improve some psychomotor driving skills when administered during the day. In real life, however, MDMA is taken during the night, and driving may likely occur early in the morning after a night of "raving" and sleep loss. OBJECTIVES: The present study assessed the effects of MDMA on road-tracking and car-following performance in on-the-road driving tests in normal traffic. METHODS: Sixteen recreational MDMA users participated in a randomized double-blind placebo-controlled four-way cross-over design. They received single, evening doses of 0, 25, 50, and 100 mg MDMA on separate occasions. Actual driving tests were conducted in the evening when MDMA serum concentrations were maximal and in the morning after a night of sleep loss. RESULTS: The primary measure of driving, i.e., standard deviation of lateral position (SDLP, a measure of weaving) was significantly increased during driving tests in the morning in all treatment conditions, irrespective of MDMA dose and concentration. The increments in SDLP were of high clinical relevance and comparable to those observed for alcohol at blood alcohol concentrations >0.8 mg/mL. These impairments were primarily caused by sleep loss. CONCLUSIONS: In general, MDMA did not affect driving performance nor did it change the impairing effects of sleep loss. It is concluded that MDMA cannot compensate for the impairing effects of sleep loss and that drivers who are under the influence of MDMA and sleep deprived are unfit to drive.

Explore topics

Comments

No comments yet.

Log in to comment